# Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan

> **NCT00898716** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 15 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** BMS-754807

## Key facts

- **NCT ID:** NCT00898716
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2011-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898716, "Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00898716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*